| Alnylam Switzerland GmbH - Onpattro 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung | | 67304 | | 01 | | Onpattro 2 mg/ml | | Konzentrat zur Herstellung einer Infusionslösung | | N07XX12 | | Patisiran | | 23.09.2019 | | |
| | Composition | | patisiranum 2 mg ut patisiranum natricum, DLin-MC3-DMA, 1,2-dimyristoyl-sn-glycero-3-carboxaminopropylpolyethylenglycoli 2000 aether methylicus, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, dinatrii phosphas heptahydricus, kalii dihydrogenophosphas, natrii chloridum, aqua ad iniectabile natrium 3.99 mg, q.s. ad solutionem pro 1 ml corresp.. | | Packungsbestandteile | | Concentré pour perfusion | | | | | | | | Principe actif | Concentr. |
|---|
| Patisiranum | 2 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Patisiranum | 2 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| 1,2-dimyristoyl-Sn-Glycero-3-Carboxaminopropylmacrogoli | 2000 | | 1,2-distearoyl-Sn-Glycero-3-Phosphocholinum | | | Aether Methylicus | | | Cholesterol | | | Disodium Phosphate Heptahydrate | | | Dlin-Mc3-dma | | | Potassium Dihydrogenophosphate | | | Sodium Chlorure | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | 7951.47 | 8466.00 | B | LS | Non |
|
|
